The biotech platform company Humacyte is merging with Alpha Healthcare Acquisition Corp. (NSDQ:AHAC) (“AHAC”), a special purpose acquisition company (SPAC). AHAC’s shareholders approved the deal today and plan to submit results from the meeting to the SEC via a Form 8-K document. The two organizations expect the merger to finalize on August 26 and stock…